Cervical Cancer Video Channel

Explore the latest insights and summaries from experts in Cervical Cancer.

Therapeutic Agents

23:46

AstraZeneca Oncology

First-line Maintenance Treatment Option in Patients With HRD-Positive Advanced Ovarian Cancer

FEATURING Sharyn Lewin
  • 567 views
  • April 29, 2024
  • 4
20:09

AstraZeneca Oncology

Management Strategies for Anemia in First-line Maintenance Therapy for Advanced Ovarian Cancer

FEATURING Diana Czel, Courtney Arn
  • 420 views
  • April 29, 2024
  • 2
19:51

AstraZeneca Oncology

Management Strategies for Fatigue and Asthenia in First-line Maintenance Therapy for Advanced Ovarian Cancer

FEATURING Diana Czel, Courtney Arn
  • 373 views
  • April 29, 2024
23:14

AstraZeneca Oncology

Management Strategies for Nausea and Vomiting in First-line Maintenance Therapy for Advanced Ovarian Cancer

FEATURING Diana Czel, Courtney Arn
  • 352 views
  • April 29, 2024
17:33

AstraZeneca Oncology

First-line Maintenance Therapy for BRCAm Advanced Ovarian Cancer Following Response to First-line Platinum-Based Chemotherapy

FEATURING Sharyn Lewin
  • 561 views
  • April 29, 2024
  • 3
07:03

Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "innovaTV 301/ENGOT-cx12/GOG-3057 Study - Efficacy & Safety of Tisotumab Vedotin vs. Investigator's Choice of Chemo in 2L/3L Recurrent/Metastatic Cervical Cancer"

FEATURING Brian Slomovitz
  • 312 views
  • April 12, 2024
  • 2
08:31

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "ALARICE Study - Avelumab With Axitinib in Persistent/Recurrent Cervical Cancer After Platinum-Based Chemo"

FEATURING Ka Yu Tse
  • 58 views
  • June 6, 2024
14:40

2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "BrUOG 354 Trial Final Results - Nivo vs. Nivo/Ipi for Ovarian & Other Extra-Renal Clear Cell Carcinomas"

FEATURING Don Dizon
  • 202 views
  • June 13, 2024
  • 1
17:20

UCLA Health

Antibody Drug Conjugates in Gynecologic Oncology: From Bench to Bedside

FEATURING Gottfried Konecny
  • 326 views
  • June 14, 2024
  • 1
06:13

ecancer

ASCO® 2024 Insights: "BrUOG 354 Trial - Nivo Alone or in Combination With Ipi for People With Ovarian and Other Extra-Renal CCCs Who Had Relapsed After Prior Therapy"

FEATURING Don Dizon
  • 105 views
  • June 21, 2024
  • 1
06:37

ecancer

ASCO® 2024 Insights: "Final OS & PFS From the AGO-OVAR 2.29/ENGOT-ov34 Study- Atezolizumab vs. Placebo in Combination With Bevacizumab + Chemo in Recurrent Ovarian Cancer"

FEATURING Frederik Marmé
  • 83 views
  • June 21, 2024
05:16

University of Miami Sylvester Comprehensive Cancer Center

Novel Treatments and Predictors of Response in Cervical Cancer

FEATURING Abdulrahman Sinno
  • 62 views
  • August 19, 2024
13:20

2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: OS Results for Pembro + CRT for High-Risk Locally Advanced Cervical Cancer - ENGOT-cx11/GOG-3047/KEYNOTE-A18

FEATURING Domenica Lorusso
  • 185 views
  • September 23, 2024
  • 2
05:38

2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Summary: Antibody Drug Conjugates (ADCs) - Identifying New Therapeutic Approaches in Gynecologic Cancers

FEATURING Susana Banerjee
  • 91 views
  • October 8, 2024
05:01

Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "The Movie Trial - Safety & Efficacy of Durvalumab + Tremelimumab + Metronomic Oral Vinorelbine in Pts With Recurrent/Metastatic Cervical Cancer"

FEATURING Jean-Sebastien Frenel
  • 79 views
  • March 19, 2024
05:31

Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "Impact of Maintenance Bevacizumab Following Chemo on Survival in Patients With Advanced & Recurrent Cervical Cancer"

FEATURING Michelle Kuznicki
  • 318 views
  • March 29, 2024
  • 3
12:21

Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "PARP Inhibitor Resistance Mechanisms in Gynecologic Cancers and Possible Solutions"

FEATURING Viola Heinzelmann-Schwarz
  • 177 views
  • March 29, 2024
  • 1
10:51

Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "The Heterogeneity of PARPi and BRCAm in Gynecologic Cancer"

FEATURING Viola Heinzelmann-Schwarz
  • 140 views
  • March 29, 2024
07:05

Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "Understanding and Targeting BRCA & HRD Mechanisms in Gynecologic Cancer"

FEATURING Viola Heinzelmann-Schwarz
  • 155 views
  • March 29, 2024
  • 1
35:35

Gyn Onc Conversations with Dr. Rimel

Insights From Dr. Mansoor Mirza: The RUBY Trial, Career Reflections, and Mentorship in Oncology

FEATURING Bobbie J. Rimel, Mansoor Raza Mirza
  • 179 views
  • July 16, 2024
17:05

Gemma Eminowicz

Induction CT Followed by Standard CRT vs. CRT Alone in Locally Advanced Cervical Cancer: GCIG INTERLACE Trial Results

  • 100 views
  • November 5, 2024
  • 2
20:51

University of Illinois Cancer Center

Treatment Updates in Cervical & Ovarian Cancer

FEATURING Jocelyn Ray
  • 66 views
  • December 4, 2024
  • 1
12:11

Oncology 2024 Year in Review

Year in Review 2024 - The Role of Medical Treatment in Cervical Cancer

FEATURING Domenica Lorusso
  • 73 views
  • December 4, 2024